Fig. 2

Prolactin levels in response to cabergoline use for 17 years. A drop in prolactin levels was observed with the cabergoline dose at 1.0 mg per week, but with no normalization of its levels. Levels were not normalized even at 3.5 mg per week, used for 44 weeks (from weeks 8 to 52). With the addition of quetiapine and mirtazapine to cabergoline, prolactin levels increased (111 weeks) and then decreased, without ever normalizing, until the last evaluation (1754 ng/ml), which was done 17 years after the start of treatment